| |
| |
|
| Insider
Information: |
Emigh James F |
| Relationship: |
VP, Corporate Developm... |
| City: |
Palatine |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
474,042 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,607 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
474,042 |
|
|
| Total
Value |
$2,607 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acura Pharmaceuticals Inc |
ACUR |
VP, Corporate Developm... |
2021-02-24 |
474,042 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACUR |
Acura Pharmaceuticals Inc |
VP, Corporate Development |
• – – |
2021-02-24 |
4 |
D |
$0.40 |
$3,020 |
D/D |
(7,550) |
474,042 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP, Corporate Development |
• – – |
2021-02-24 |
4 |
OE |
$0.15 |
$3,020 |
D/D |
20,000 |
481,592 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP, Corporate Development |
• – – |
2021-01-04 |
4 |
D |
$0.21 |
$1,554 |
D/D |
(7,402) |
461,592 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP, Corporate Development |
• – – |
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,667 |
468,994 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP, Corporate Development |
• – – |
2020-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,667 |
444,327 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Corporate Development |
• – – |
2017-12-14 |
4 |
B |
$0.10 |
$40,000 |
D/D |
400,000 |
439,660 |
2.74 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Corporate Development |
• – – |
2014-05-16 |
4 |
B |
$1.21 |
$18,149 |
D/D |
15,000 |
198,304 |
2.74 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Corporate Development |
• – – |
2014-01-24 |
4 |
OE |
$1.30 |
$8,093 |
D/D |
6,225 |
183,304 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Corporate Development |
• – – |
2013-05-03 |
4 |
OE |
$1.30 |
$8,093 |
D/D |
6,225 |
177,079 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Corporate Development |
• – – |
2013-01-01 |
4 |
D |
$2.22 |
$14,643 |
D/D |
(6,596) |
170,854 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Corporate Development |
• – – |
2012-01-27 |
4 |
OE |
$1.30 |
$8,093 |
D/D |
6,225 |
177,450 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Marketing & Administration |
• – – |
2011-08-12 |
4 |
B |
$2.56 |
$13,013 |
D/D |
5,000 |
171,225 |
2.74 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Marketing & Administration |
• – – |
2011-01-21 |
4/A |
OE |
$1.30 |
$8,093 |
D/D |
6,225 |
166,225 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Marketing & Administration |
• – – |
2011-01-21 |
4 |
OE |
$1.30 |
$8,093 |
D/D |
6,225 |
189,225 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Marketing & Administration |
• – – |
2009-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
160,000 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Marketing & AdministrationO |
• – – |
2007-10-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,420,000 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
